Session Item

Overview: This mind-challenging debate focuses on whether treating physicians or patients themselves should be in charge for follow-up after breast cancer treatment. By discussing the possible value of early detection of recurrences, the definition of high-risk patients, tools to detect recurrences, needs for evaluation of side effects, optimisation of physical and psychological well-being, and physical as well as emotional costs of follow-up examinations and visits, the debaters will try to convince us of their viewpoints. They will focus on patients’ and clinicians’ perspectives, patients’ empowerment, and not avoid a black & white position. A not to be missed debate!